Efficacy of Integrated Mental Health Care with Dual Diagnosis Patients and Their Utilization of Psychiatric Emergency Services by Scott, Denton
The University of San Francisco
USF Scholarship: a digital repository @ Gleeson Library |
Geschke Center
Doctoral Dissertations Theses, Dissertations, Capstones and Projects
Spring 5-17-2019
Efficacy of Integrated Mental Health Care with
Dual Diagnosis Patients and Their Utilization of
Psychiatric Emergency Services
Denton Scott
University of San Francisco, beauscott15@gmail.com
Follow this and additional works at: https://repository.usfca.edu/diss
Part of the Clinical and Medical Social Work Commons, Clinical Psychology Commons,
Community Health Commons, Community Psychology Commons, Counseling Commons, Health
Psychology Commons, Multicultural Psychology Commons, Other Mental and Social Health
Commons, Psychiatry and Psychology Commons, Psychoanalysis and Psychotherapy Commons,
and the Substance Abuse and Addiction Commons
This Dissertation is brought to you for free and open access by the Theses, Dissertations, Capstones and Projects at USF Scholarship: a digital
repository @ Gleeson Library | Geschke Center. It has been accepted for inclusion in Doctoral Dissertations by an authorized administrator of USF
Scholarship: a digital repository @ Gleeson Library | Geschke Center. For more information, please contact repository@usfca.edu.
Recommended Citation
Scott, Denton, "Efficacy of Integrated Mental Health Care with Dual Diagnosis Patients and Their Utilization of Psychiatric
Emergency Services" (2019). Doctoral Dissertations. 482.
https://repository.usfca.edu/diss/482
 
 
The University of San Francisco 
 
 
 
Efficacy of Integrated Mental Health Care with Dual Diagnosis Patients and  
Their Utilization of Psychiatric Emergency Services 
 
 
 
 
A Dissertation Proposal Presented to  
The Faculty of the Department of Integrated Healthcare  
School of Nursing and Health Professions 
 
 
 
 
 
In Partial Fulfillment of the Requirement for the  
Degree of Doctor of Clinical Psychology 
 
 
 
 
 
 
 
by Beau Scott 
Santa Cruz 
May 2019 
 
EFFICACY OF INTEGRATED MENTAL HEALTH CARE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © 2019 
by 
Beau Scott 
 

EFFICACY OF INTEGRATED MENTAL HEALTH CARE iv 
 
TABLE OF CONTENTS 
Specific Aims ............................................................................................................................. 1 
Chapter I: Introduction................................................................................................................ 2 
Chapter II: Review of the Literature ............................................................................................ 4 
Overview of Opioids ............................................................................................................... 4 
Opioid Use Disorder and Dual Diagnoses: Definition and Prevalence ..................................... 4 
Opioid Addiction Treatment ................................................................................................. 10 
Therapeutic Interventions Within the Medical Maintenance Treatment Model ...................... 13 
Overview of Psychiatric Emergency Services (PES) in the United States .............................. 21 
PES and Patients with Dual Diagnosis .................................................................................. 24 
Consequences of Frequent Use of PES on United States’ Healthcare System and 
Economy .............................................................................................................................. 26 
Bay Area Addiction and Research Treatment (BAART): An Integrated Clinical Model ........ 28 
Significance of Research Project for Clinical Psychology ......................................................... 30 
Main Research Questions...................................................................................................... 32 
Chapter III: Methods................................................................................................................. 33 
Design .................................................................................................................................. 33 
Participants ........................................................................................................................... 33 
Materials............................................................................................................................... 36 
Procedure ............................................................................................................................. 36 
Purpose ................................................................................................................................. 38 
Chapter IV: Evaluation/Analytic Plan and Results .................................................................... 39 
Preliminary Analyses ............................................................................................................ 39 
Evaluation of Parametric Assumptions and Conceptual Plan ................................................. 39 
Tests of Hypotheses .............................................................................................................. 40 
Chapter V: Discussion .............................................................................................................. 45 
SAC Only Versus SAC and MHC ......................................................................................... 45 
Females Versus Males .......................................................................................................... 45 
Age Correlation .................................................................................................................... 46 
Clinical Implications ................................................................................................................. 47 
Clinical Competence and Training ........................................................................................ 47 
Healthcare Costs ................................................................................................................... 48 
EFFICACY OF INTEGRATED MENTAL HEALTH CARE v 
 
Methadone Clinics ................................................................................................................ 49 
Substance Abuse in General .................................................................................................. 50 
New Model for All Dual Diagnoses ...................................................................................... 51 
Training ................................................................................................................................ 53 
Study Limitations ..................................................................................................................... 54 
Diagnosis Variability ............................................................................................................ 55 
Data Limitations ................................................................................................................... 55 
Direction for Future Research ................................................................................................... 57 
References ................................................................................................................................ 60 
Appendix A: IRB Application Procedure .................................................................................. 74 
Appendix B: IRB Application ................................................................................................... 75 
Appendix C: IRB Waiver Response .......................................................................................... 78 
Appendix D: City and County of San Francisco Department of Public Health, DPH 
Research Proposal Approval ..................................................................................................... 79 
Appendix E: City and County of San Francisco Department of Public Health, DPH 
Health Information Data Use Agreement .................................................................................. 82 
 
LIST OF TABLES 
 
Table 1. Demographic Data................................................................................................... 39 
 
LIST OF FIGURES 
 
Figure 1. Bivariate scatterplot of PES and age, for SAC-only group ....................................... 42 
Figure 2. Bivariate scatterplot of PES and age, for SAC & MHS group .................................. 43 
Figure 3. Bivariate scatterplot of PES and age, for both groups combined .............................. 44 
 
  
EFFICACY OF INTEGRATED MENTAL HEALTH CARE vi 
 
Dedication 
This dissertation, and my work hereafter, is dedicated to all those still suffering from mental 
illness and addiction. May you all become the best version of yourselves—humbly and 
sustainably. And for all those that have supported my path and believed in me—from friends, 
family, and professors, to mentors and magicians.   
 
  
EFFICACY OF INTEGRATED MENTAL HEALTH CARE vii 
 
Acknowledgments 
I want to thank my parents for making me possible and always believing in me, even 
when I was unable to believe in myself. My sister, Aimee, for her overwhelming generosity and 
constant demonstration of “next level “creativity. My other sister, Monique, for looking after me 
as if I were her own from day one.  To my son, Reese, for stepping up and running our 
household as I was commuting from Santa Cruz to San Francisco for 4 years. You are the reason 
I am the man I am today. Your existence on this earth inspired me to be the best human I could 
be.  My chair, Dr. Ferm, for being a mentor, a director, a friend, and for escorting me to the 
finish line—I am forever grateful and could write a book on how much you have impacted my 
life. To Dr. Montagno for being just about everything (chair, advisor, program director, 
inspirer…) for me since starting my doctorate studies. I could not hold you in higher regard and 
could not have made it without you. I am forever in your debt.  To Dr. Wright, for demonstrating 
what a remarkable human being looks like on a daily basis. Your unassuming brilliance and 
constant concern for the betterment of those less fortunate is quite humbling. I am a better person 
for having known you. To Dr. Manuel, for seeing me as I am and believing in what I can do. 
Because you believed in me, I believe in me, what a gift.  To Dr. Davis, for making my 
internship amazing and for generously giving me the time and support to complete my 
dissertation during my internship. You are a difference maker. To my new stairchildren, Tethys, 
Lucas, and Cleo, who have welcomingly accepted me into their lives and made it precious 
beyond words. Lastly, to my wife, Jennifer, the love of my life. Your love, support, and 
brilliance blows my mind every single day and has provided me with the confidence and 
inspiration necessary to complete this seemingly insurmountable dissertation. You have single-
handedly made me the luckiest man alive. That I know for sure.  
EFFICACY OF INTEGRATED MENTAL HEALTH CARE viii 
 
Abstract 
 
Historically, patients with dual diagnosis have been subjected to ineffective treatment and 
negative attitudes from healthcare providers. Further, these patients are plagued with myriad 
afflictions that exist beyond substance abuse and mental illness. The treatments and collateral 
damage associated with the diagnosis impose excessive healthcare costs and can be of significant 
detriment to society.  Largely, patients suffering from dual diagnosis do not receive adequate 
treatment. As such, psychiatric emergency services are frequently utilized as an alternate 
treatment, wherein the main focus of care is on the substance abuse alone. This study argues that 
solely treating the substance abuse is not sufficient for positive outcomes because the substance 
use, in most cases, is merely a self-discovered treatment for an underlying mental illness. This 
study proposes an integrative model that involves both substance abuse counseling and mental 
health counseling in order to treat this suffering population more effectively. 
Using archival data from the years 2014–2017, this study examined the effectiveness of 
integrative care among dual diagnosis patients at a methadone clinic in San Francisco, 
California. The study measured whether patients with dual diagnosis, who were assigned to both 
Substance Abuse Counseling (SAC) and Mental Health Counseling (MHC), differ in the mean 
number of Psychiatric Emergency Services (PES) visits from patients with dual diagnosis 
receiving SAC alone. Additionally, this study measured whether females and males differ in the 
mean number of PES visits and whether age positively or negatively correlates with the number 
of PES visits. Independent samples t-tests were used to measure mean differences of PES visits 
between treatment groups (MHC+SAC vs. SAC only) and mean difference of PES visits 
between gender.  Pearson correlation was used to measure correlation between age and PES 
visits.  
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Results revealed that patients receiving integrative care (MHC+SAC) had fewer PES 
visits than those receiving SAC only, suggesting that integrative care is a more effective 
treatment model than SAC only when treating  patients with dual diagnosis. Additionally, 
although females accessed PES less than males, there were no statistically significant differences 
found. Lastly, there was no correlation found between age and number of PES visits.   
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Specific Aims 
Dual diagnosis is defined as a substance abuse disorder concurrent with a mental disorder 
(Mehr, 2001). This population is underserved and plagued by stigma (Conner & Rosen, 2008). 
The literature identifies that patients with dual diagnosis are not receiving adequate treatment. 
Most often, only the substance abuse is being treated, and the psychiatric issues are overlooked. 
Van Boekel, Brouwers, Van Weeghel, and Garretsen (2013) report that, in general, healthcare 
professionals have negative attitudes towards patients with any type of substance abuse disorder.   
Historically, this population overutilizes PES. Because this population is not being 
treated appropriately or effectively, and their options for treatment are limited, not only are PES 
being overused, they have also become an alternative treatment option that is both ineffective 
and expensive.  
Methadone clinics are a common destination for patients with dual diagnosis. In 2010, 
Bay Area Addiction Research Treatment (BAART) began implementation of an integrative 
approach by adding mental health services in conjunction with substance abuse counseling for 
their dual diagnosis patients.  This study explored the effects of integrative counseling on PES 
utilization by using archival data at BAART. Essentially, the researcher measured the correlation 
between SAC and MHC sessions with total PES visits. Counseling effectiveness (independent 
variable) was  measured by total number of PES utilized (dependent variable), between 2014 and 
2017.  
This study aligns with the Jesuit mission in its support, defense, and service for an 
underserved population—those who are economically disadvantaged, homeless, uninsured, of 
racial and/or ethnic minority, living with human immunodeficiency and/or other chronic 
conditions, including mental illness and illicit substance abuse (Knickman, Bethell, Fiorillo, & 
Lansky, 2002).  
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Chapter I: Introduction 
The opioid epidemic is a staggering problem in the United States (Rassool, 2006; Rudd, 
2016) and illicit opioid use is a major contributing factor in all opioid deaths (Gladden, 2016; 
Peterson, 2016). Prior research reports that opioids cause more deaths than suicide, automobile 
accidents, and cocaine combined (Cifuentes, Webster, Genevay, & Pransky, 2010; Manchikanti 
et al., 2012; Stover et al., 2006). Drug overdose has virtually tripled in the United States between 
1999 and 2014. Among overdose deaths in 2014, 60.9 % involved an opioid (Rudd, 2016).  
Methadone is the most commonly used pharmaceutical treatment for those who seek 
reprieve from opioid addiction. In the state of California, methadone clinics are required to 
provide SAC but not MHC. SAC involves weekly sessions wherein the counselor monitors the 
patients’ substance use and recovery. If a patient misses more than two sessions, the substance 
abuse counselor can have their methadone dose stopped until patient returns for their weekly 
sessions.  Mental health counseling is comprised of weekly 50-minute psychotherapy sessions 
with a mental health counselor that aims at exploring and resolving psychological ailments and 
treating mental disorders such as, general anxiety, mood disorders, psychotic disorders, 
personality disorders, and more. The mental health counselors apply various evidence-based 
treatments such as, Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy 
(ACT), Dialectical Behavioral Therapy (DBT), Motivational Interviewing (MI), and 
Motivational Enhancement Therapy.  The common goal of MHC is to: alleviate distress, 
decrease symptoms, and improve functionality and overall well-being.  
The origins of methadone and how it has evolved into its current position of treating 
opiate addiction worldwide are explored in the present study. Moreover, this study examined the 
use of PES among patients with dual diagnosis and explored if MHC provision reduces PES 
visits for dual diagnosis patients in methadone clinics.  Participant data from between 2014 and 
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2017 was collected from Avatar and Methasoft. Methasoft is the electronic database used by 
substance abuse counselors, whereas Avatar is the electronic database that mental health 
counselors use. 
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Chapter II: Review of the Literature 
Overview of Opioids  
Opioids are analgesics, what are commonly referred to as “painkillers.” However, the 
effects go far beyond basic pain relief. Humans have opioid receptors that are found in the brain, 
spinal cord, and gastrointestinal tract. When an individual takes an opioid, the opioid attaches to 
these receptors, blocking the perception of pain (Jamison & Mao, 2015). 
This area of the brain affected, the nucleus accumbens, is also associated with perceived 
pleasure, which translates into the individual simultaneously experiencing pleasure. This 
pleasure is often intensified when the opioid is taken by a non-recommended administration, 
such as snorting or intravenous injection. Along with the euphoria produced by the incorrect 
administration of opioids comes potentially dire consequences, such as severe drowsiness, 
nausea, respiratory depression, addiction, and in many cases, death by overdose (Kosten & 
George, 2002). 
Medically, opioids are used to relieve or mediate moderate to severe pain (Ferrari, 
Capraro, & Visentin, 2012). Prolonged use of opioids will eventually produce a tolerance, 
meaning progressively higher doses will be required to generate the initial effects (Jamison & 
Mao, 2015). 
Opioid Use Disorder and Dual Diagnoses: Definition and Prevalence  
Opioid use disorder. Defined as a repetitive occurrence of two or more of eleven criteria 
over a 12-month period, opioid use disorder (OUD) was added to the Diagnostic and Statistical 
Manual of Mental Disorders 5 in 2013 (Brady, McCauley, & Back, 2015). OUD is marked by 
giving up important life events in order to use opioids, excessive time spent using opioids, and 
withdrawal (Association, 2013; Brady et al., 2015), with diagnostic specifiers including: in early 
remission, in sustained remission, maintenance therapy, and in controlled environment.  A 
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patient is considered to be in early remission if they previously met all criteria for opioid use 
disorder but exhibit no symptoms, except for cravings, for at least 3 months. A patient is 
considered to be in sustained remission if they previously met all criteria for opioid use disorder 
but currently exhibit no symptoms, except for cravings, for at least 12 months. When an 
individual is in sustained remission they have not presented with symptoms other than craving 
for at least 12 months. Maintenance therapy indicates an individual is being prescribed agonists 
(a substance that initiates a physiological response when combined with a receptor) such as 
buprenorphine or methadone, but no criteria for that particular class of medication has been met. 
Maintenance therapy also includes persons being prescribed and maintained on partial agonists, 
agonists/antagonists, or full antagonists, such as naltrexone or a deport naltrexone (Association, 
2013). If one is housed in an environment that restricts opioids, then the specifier in a controlled 
environment is used. This classification includes substance abuse treatment centers, hospitals, 
and correctional facilities.  
Opioid use disorder can be mild, moderate, or severe. A diagnosis of mild opioid disorder 
requires the presence of only 2–3 of the 11. A person presenting with 4–5 symptoms is 
considered to have moderate opioid use disorder. If one has 6 or more symptoms they are 
considered to have severe opioid disorder (Association, 2013).  The pattern of opioid use 
disorder closely resembles other chronic relapsing illnesses such as diabetes and hypertension, 
wherein symptom management is often difficult and patient compliance with treatment is 
compromised.  Ultimately, the course of this disorder involves stages of exacerbation and 
remission while the underlying susceptibility never seems to dissolve (Schuckit, 2016).  
Opioid abuse prevalence. Rates of the use of illegal opiates continue to rise.  According 
to Rudd (2016), the rates of heroin use and non-medical use of prescribed opioids have reached 
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epidemic levels. In the United States, between 2002 and 2013, heroin use increased by 62% 
(Jones, Logan, Gladden, & Bohm, 2015). Approximately 914,000 Americans have used heroin 
within the past year. An additional 403,000 have abused non-medical prescription opioids 
(Hedden, 2015). Between 2001 and 2013, heroin overdose fatalities increased 5 times and non-
medical prescription opioid abuse has increased trifold (Rudd, 2016).  
Dual diagnoses. Historically, individuals with substance abuse issues have been referred 
to as “addicts” and, more specifically for the opioid abuser, “junkies.” While the label “junkie” 
singularly focuses on the drug abuse, most often the addict is seeking to medicate an underlying 
mental illness. Individuals with both substance use disorder(s) and at least one mental illness are 
considered to be persons with dual diagnosis. Individuals with dual diagnosis repeatedly find 
themselves using PES for myriad reasons, often because the attention of care is focused on the 
substance use, not the underlying mental illness (Arfken et al., 2004). Both substance abuse and 
mental illness can pose acute distress on an individual—impairing function and even leading to 
fatalities—independent of one another.  When these conditions occur simultaneously, the 
potential for acute distress is magnified. For these reasons, individuals with dual diagnosis often 
over populate psychiatric emergency services (Baillargeon et al., 2008; Lukens et al., 2006; 
Slade et al., 2007). This trend is the central reason for this research. 
Individuals that are dually diagnosed have been labeled in multiple ways using various 
phrases and acronyms. (Mehr, 2001) reports informal terms such as “double–troubled,” “dually 
troubled” or “dually diagnosed patients.” Acronyms such as MISA (mental illness/substance 
abuse), COAMD (co-occurring addictive and mental disorder), ICOPSD (individuals with co-
occurring psychiatric and substance abuse disorder), MICA (mental illness/chemical abuse), 
SAMI (substance abuse/mental illness), and CAMI (chemical abuse/mental illness) have also 
EFFICACY OF INTEGRATED MENTAL HEALTH CARE 7 
 
been used in prior literature and clinical practice. Essentially, they all share the same qualities:  a 
concurrent diagnosis of substance abuse or alcoholism and a mental illness. For the sake of this 
research, the use of “dual diagnosis” refers to the participants in studied population (Mehr, 
2001).  
Due to its complex and multidimensional nature, dual diagnosis is a challenge to define, 
and there has been controversy regarding the term (Phillips, McKeown, & Sandford, 2009), 
suggesting that healthcare professionals need to be careful of the everyday language they use in 
practice. Rorstad and Checinski (1996) argue that the term dual diagnoses is “labelling of the 
worse kind.” Nonetheless, Todd et al. (2004) provide a simple and concise definition of dual 
diagnosis:  the co-occurrence of one or more mental illness (MI) and a substance use disorder 
(SUD). 
Dual diagnosis is one of the leading problems in healthcare services to date (Rassool, 
2006).  In general hospitals, a large percentage of patients are admitted due to complications with 
alcohol or illicit substances (Heslin, Elixhauser, & Steiner, 2015; Lehman, Myers, & Corty, 
2000). Lehman and colleagues (2000) report that the co-occurrence of a mental disorder and a 
substance abuse disorder happen more often than chance would predict. Heslin et al. (2015) 
report that in 2012, hospital inpatient stays in the US reached 8.6 million (32.3% of all inpatient 
stays) for patients with either a mental disorder or substance use disorder, and 1.8 million (6.7%) 
of those inpatient stays were patients with a co-occurring mental disorder and substance abuse 
disorder. 
The trajectory for those with dual diagnosis is challenging.  Those with dual diagnosis 
typically experience onset in their youth, which develops into a chronic course (Di Lorenzo, 
Galliani, Guicciardi, Landi, & Ferri, 2014) and is associated with poor treatment compliance, 
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higher relapse rates, and more psychiatric symptoms than psychiatric symptoms alone (Archie & 
Gyomorey, 2009; Zammit et al., 2008). Additionally, although the literature does not 
consistently report identical correlations, it does extensively identify that patients with dual 
diagnoses are associated with greater risk for HIV and hepatitis (Hoff & Rosenheck, 1999), 
unemployment (Laudet, Magura, Vogel, & Knight, 2002), incarceration (McNiel, Binder, & 
Robinson, 2005), suicide (Soyka, Albus, Immler, Kathmann, & Hippius, 2002), 
violence/delinquency (Soyka, 2000), hospitalization (Archie & Gyomorey, 2009; Haywood, 
Kravitz, Grossman, & Cavanaugh Jr, 1995; Schmidt, Hesse, & Lykke, 2011), and homelessness 
(Olfson, Mechanic, Hansell, Boyer, & Walkup, 1999).  
The literature indicates that, in many cases, dual diagnosis patients are not treated 
appropriately or with respect. Hansen et al. (2000) report that one of the reasons for mistreatment 
and lack of respect may be physicians’ difficulties differentiating between the symptoms of 
mental illness (MI) and the symptoms of a substance use disorder (SUD). One of the suggestions 
for appropriate and respectful treatment is an integrated approach (Drake, Mueser, Brunette, & 
McHugo, 2004; Mangrum, Spence, & Lopez, 2006; Mueser, 2003), in which both the SUD and 
MI are treated as primary disorders. Another possible reason for the mistreatment and disrespect 
of the patient with dual diagnosis may be the clinical incompetence of mental health 
professionals and medical professionals alike to detect and treat dual diagnosis patients due to 
the chronic and acute effects (Barry, Tudway, & Blissett, 2002; Cleary, Hunt, Matheson, & 
Walter, 2009; Griffin, Campbell, & McCaldin, 2008; Morojele, Saban, & Seedat, 2012), which 
may be further explained by entrenched, negative attitudes toward this particular population 
(Adams, 2008; Richmond & Foster, 2003). Pinderup, Thylstrup, and Hesse (2016) attribute 
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negative attitudes toward dual diagnosis patients and the mistreatment of them to the lack of 
clinical training for this population.  
Dual diagnosis prevalence. The prevalence of the dual diagnosis population is striking. 
Regier et al. (1990) report that the Epidemiological Catchment Area (ECA) study discovered 
that, over a lifespan, the rate for SUD was 17% compared to 48% of persons on the 
schizophrenic spectrum and 56% of persons with bipolar disorder. More recently, Toftdahl, 
Nordentoft, and Hjorthøj (2016) found that the prevalence of those individuals with SUD and MI 
was 11% with OCD; 17% with PTSD; 25% for depression; 25% for anxiety; 28% for other 
psychoses; 32% for bipolar; 35% for schizotypal; 37% for schizophrenia; and 46% for 
personality disorders. Left untreated, these diagnoses have severe consequences on both 
individuals and society, including but not limited to homelessness, violence, increased severity 
of mental illness, HIV status, and healthcare costs (Mehr, 2001). 
Awareness of this increasing pattern of coexisting mental health and substance use has 
been growing for some time in the United States (Regier et al., 1990), and more recently in the 
United Kingdom. The National Comorbidity Survey (NCS) discovered that among those with 
lifetime SUD, 41.0%–65.5% have at least one mental disorder and of those with a mental 
disorder, 50.9% have at least one SUD (Kessler et al., 1996).  In May of 1996, a report designed 
to formulate a strategy to determine effective treatment for drug misusers by the Department of 
Health stated that “Purchasers and providers should ensure that people working in both drugs and 
mental illness services are aware of the need to identify and respond to problems of combined 
psychiatric illness and drug misuse” (Department of Health, 1996). In 2003, the U.S. Substance 
Abuse and Mental Health Services Administration (SAMHSA) conducted an epidemiological 
study which found that, of adults aged 18 years and older, there were 19.6 million with severe 
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mental illness. Of those 19.6 million adults, 27% used an illicit drug within the last year and 21% 
of them were dependent on drugs as opposed to 13% and 8% of adults without a mental illness 
(Buckley, 2005). In 2016, SAMSHA reported that 8.2 million adults had any mental illness 
(AMI) and an SUD, and 50% of them did not receive treatment for either. Additionally, 2.6 
million people had a severe mental illness (SMI) and an SUD, and 1/3 of them did not receive 
treatment for either (Park-Lee, Lipari, Hedden, Copello, & Kroutil, 2016).  
This is precisely why it is absolutely critical to treat both SUD and MI of individuals with 
dual diagnosis in order to decrease their use of psychiatric emergency facilities, which provide 
poor treatment for these particular individuals and also costs the United States’ economy billions 
in healthcare dollars (Heslin, Elixhauser, & Steiner, 2015). 
Opioid Addiction Treatment 
Pharmaceutical intervention for opioid addiction. To date, the leading medical 
treatments approved by the FDA for opioid use disorder are buprenorphine, naltrexone, and 
methadone (Kampman & Jarvis, 2015).  
Buprenorphine is a partial agonist that has both agonistic and antagonistic properties 
(Foltin & Fischman, 1996).  Just like methadone, buprenorphine can be used for both 
maintenance and detoxification purposes for those being treated for opioid addiction. 
Buprenorphine can also be effective with one dose per day (Dugosh et al., 2016).  
Naltrexone, on the other hand, is used primarily for maintenance. An opioid antagonist 
that binds to opioid receptors for 24–30 hours, naltrexone substantially blocks the effects of 
incoming opioids, and in most cases, eliminates the effects completely (Dugosh et al., 2016). In 
other words, if an individual administers opiates into their system within 24–30 hours of a 
naltrexone dose, they will not experience the effects of the opioid.  
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Methadone is a long-lasting opioid agonist (approximately 24–30 hours), which typically 
allows the patient to only need to dose daily. These long-acting effects are the principal 
advantage of methadone for treating opioid abuse. It is used to decrease withdrawals in the 
detoxification process and is also used as a maintenance treatment to decrease non-medical 
use/abuse of opioids (Dugosh et al., 2016). 
Methadone: origins and current application. In the nineteenth century, opioid use was 
viewed with less stigma than alcoholism. Those who abused opioids were typically from 
respectable families and were not associated with any criminal activities (Lindesmith, 1968). 
Interestingly, opioids were often used to treat alcoholism—they were less expensive than alcohol 
and individuals were less destructive when under the influence of opioids versus alcohol.  
Because of a heavy increase in opioid addiction and overprescribed opioids, 25,000 physicians 
were arraigned by 1938 on narcotic charges for treating addiction and alcoholism with opioids. 
Subsequently, this line of treatment was temporarily suspended (Dole & Nyswander, 1965; 
Payte, 1991; Renner Jr, 1984).  
Toward the end of the World War II, addiction to narcotics in the United States had 
essentially come to an end (Inciardi, 1986). According to Payte (1991), it was not because of 
successful treatments but because resources for morphine from Asia had been stymied due to 
conflicts of war. Meanwhile, there was a theory that Hitler had scientists creating an alternative 
to morphine.  Ultimately, German scientists at I.G. Farbenindustrie, a chemical and 
pharmaceutical industry conglomerate at Hoechst-am Main, Germany, who worked closely with 
the Nazi regime, discovered amidon(e) with the trade name Dolphine, Today, this morphine 
alternative is known as methadone (Renner Jr, 1984).  
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It would still be over a decade before the United States would utilize methadone as a 
maintenance treatment for opiate addiction, specifically because of the Narcotic Control Act of 
1956, which criminalized and detained those involved in narcotics (Payte, 1991). After its 
passage, the climate surrounding the character of opioid users shifted from benign to criminal. 
Consequently, Payte (1991) states physicians were hesitant to be involved in any form of 
treatment of addiction that organized medicine’s willingness to treat addiction was halted. 
Conversely, the US narcotic addiction epidemic was increasing and other forms of 
treatment such as hospitalization, detoxification and release, and abstinence were not proving 
effective. By the late 1950s and early 1960s it became increasingly obvious that detox and 
release and complete abstinence were not working. Interests began to revert back to a 
pharmacological/medical maintenance treatment approach (Newman & Cates, 1977; Renner Jr, 
1984).  Waldorf (1973) reports that in 1963, the New York City Health Council awarded Dr. 
Vincent Dole a research grant for medical maintenance treatment of opioid addiction.  Despite 
resistance from the U.S. Bureau of Narcotics, methadone maintenance treatment (MMT) for 
addiction began to evolve. 
During the first 2 months of medical maintenance treatment for addiction, Dole and his 
colleagues were administering patients with daily doses of up to 600 mg of morphine parentally 
(Dole & Nyswander, 1965; Payte, 1991). Quickly, researchers noticed the morphine dosages 
needed were excessively high (up to 600 mg), tolerances were increasing rapidly, and the 
patients seemed dissociated and passive, only sitting and patiently waiting for their next injection 
(Dole & Nyswander, 1965; Louria, Hensle, & Rose, 1967). At this point, clinicians began 
administering a replacement of 150–180 mg of methadone by mouth. The patients responded 
well to this adjustment and showed interest in purposeful activity and engagement. In sum, 
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researchers found that, unlike morphine and other opiates, there was an optimal dose wherein 
patients could achieve a stable state without having to continuously increase the dosage. Each 
person had their own threshold of effective dosage, which was determined by titrating the patient 
until relief from opiate withdrawal symptoms was reached (Dole & Nyswander, 1965). The same 
method of determining the effective dosage is still used today (Newman & Cates, 1977; Renner 
Jr, 1984; Zweben & Payte, 1990). 
Presently in the United States, maintenance treatment with methadone is offered by 
approved clinics that are closely monitored and regulated by state and federal laws (Ball & Ross, 
2012). The clinics require almost daily participation by the patient in order to receive the 
methadone, which means that the patient is required to come to the clinic nearly every day in the 
beginning of treatment to receive their dose (Mattick, Breen, Kimber, & Davoli, 2009). Take-
home methadone doses are permitted by those patients who adhere to the clinic rules and 
regulations over time (Schuckit, 2016).  
Therapeutic Interventions Within the Medical Maintenance Treatment Model 
In 2007, Assembly Bill 2071 (AB2071) was passed in California, mandating methadone 
clinics to provide a minimum of 50 minutes of SAC to methadone patients. MHC, however, was 
not required (Kletter, 2003). As previously mentioned, opioid use disorder is often accompanied 
by another underlying or primary mental disorder (Lehman et al., 2000). Consequently, it is 
vitally important that both ailments be addressed.  
As part of a comprehensive treatment for opioid addiction, Medical Maintenance 
Treatment (MMT) has been approved for practice within the context of social, medical, and 
psychological support. Nonetheless, there is minimal research addressing the effectiveness of 
MMT in combination with mental health treatment interventions (Dugosh et al., 2016). When 
providing mental health treatment interventions, the aim is to help patients control compulsions 
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to use and sustain abstinence, while at the same time helping them manage the emotional discord 
that often comes with addiction (Dugosh et al., 2016). The literature indicates that in general, a 
relatively small number of patients with dual diagnosis are receiving MMT and various mental 
health treatment interventions. Some of these interventions include Cognitive Behavioral 
Therapy (CBT), Acceptance and Commitment Therapy (ACT), and general support counseling. 
All of these interventions are used to augment medical maintenance treatment of substance 
misuse. 
CBT. Prior studies show that patients with dual diagnosis who were assigned to MMT 
both did and did not differ from patients who were assigned to MMT and CBT group, as well as, 
MMT and Recovery Line (RL) group in studied variables described below (Kouimtsidis, 
Reynolds, Coulton, & Drummond, 2012; Moore et al., 2012).  
Kouimtsidis et al. (2012) conducted a study that examined the efficacy of providing CBT 
in combination with standard MMT as opposed to MMT alone. The sample consisted of both 
males and females between 18 and 70 years old. Ethnicity, race, and socioeconomic status were 
not provided. Participants were either assigned to MMT only (n=31) or MMT plus CBT (n=29).  
MMT participants received bi-monthly sessions that involved manual-directed sessions. The 
MMT plus CBT group were offered 50-minute one-on-one CBT sessions weekly and could 
attend up to 24 sessions over a 6-month period of time.  The primary outcome measures were 
percentage of days abstinent from heroin and the amount of money spent on heroin in the past 
180 days. Secondary outcome measures consisted of addiction severity, severity of drug 
dependence, quality of life, psychological symptoms, and methadone treatment compliance.  The 
groups did not yield significant differences in primary or secondary outcome measures. MMT 
plus CBT participants did, however, show significant increases (P < 0.02) in their positive 
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appraisal at the 6-month check-in assessment. They also showed significantly lower (P < 0.05) 
emotional discharge at the 12-month assessment stage than the MMT group.  
In a similar study, Moore et al. (2012) randomized participants to either MMT only 
(n=18) or MMT plus Recovery Line (RL) (n=-18) over a 4-week period. RL was defined as an 
interactive voice response system based on CBT principals that included coping skill rehearsal, 
goal setting, and self-monitoring.  The MMT plus RL group also attended a RL orientation, 
received weekly reminders to utilize the system, a manual explaining RL, and had 24-hour 
access to the RL system for the entire 4 weeks of the study. MMT only group was granted one-
on-one psychosocial sessions over the 4-week span of the study. They were also encouraged to 
attend open groups that covered topics such as spirituality, overdose preparation, scheduling of 
activities, and methadone. The groups did not differ in study retention, MMT satisfaction, self-
reported substance use, urinalysis-verified opioid and cocaine abstinence, coping skills, or 
number of sessions attended beyond the minimum required (Kouimtsidis et al., 2012; Moore et 
al., 2012). However, RL group did reveal that they were more likely to report cocaine and opioid 
abstinence on days that they utilized RL relative to the days that they did not.  
Based on these studies, patients with dual diagnosis are difficult to treat even using 
additional mental health interventions such as CBT and RL. However, there are some findings 
that patients with dual diagnosis report significantly greater positive appraisal (P < 0.02) and 
lower emotional discharge over time (P < 0.05). However, there are no longitudinal studies to 
date, therefore, future research needs to measure these outcomes over time through longitudinal 
studies. 
ACT. Prior studies reveal that patients with dual diagnosis who were assigned additional 
Acceptance and Commitment Therapy (ACT) treatment showed mixed results from patients that 
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were assigned drug counseling (DC) alone. The same applied to those assigned to treatment as 
usual (TAU).  
In one study, Stotts (2012) randomized participants to one of two groups: Drug 
Counseling DC group (n=26) and ACT group (n=30). The DC group was comprised of 24 
weekly sessions lasting 50 minutes, which addressed abstinence-oriented behaviors and support 
during a 6-month methadone reduction phase. Those in the ACT group received 24 weekly 
sessions lasting 50 minutes. The sessions addressed fears around the detoxification process and 
experiential avoidance during the stabilization phase, continuing through the dose reduction 
phase of the study. Although the “fear of detoxification” among the participants in the ACT 
group was reduced over time relative to those in the DC group, the study found no significant 
differences between the groups regarding severity of opioid withdrawal, opioid use, treatment 
attendance, completion or success, or engagement in HIV/HCV risk behaviors. 
In another study, Thekiso et al. (2015) added ACT to an integrated treatment approach 
used to treat dual diagnosis patients at St. Patrick’s University Hospital in their inpatient 
substance abuse program. The integrated approach, referred to as Treatment As Usual (TAU), 
included extensive pharmaceutical interventions, behavioral activation, and 12-step groups. The 
aim of the study was to determine if adding ACT interventions would improve TAU outcomes.  
The study consisted of two groups, an ACT group and TAU group. Inclusion criteria for 
the ACT group (N=26) were: 18 years or older, capable of providing informed consent, met 
criteria for Alcohol Dependence and either Major Depression Disorder or Bipolar Disorder, and 
being enrolled in the St. Patrick’s University Hospital inpatient integrated treatment program 
(Farren & McElroy, 2008).  
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Archival data were used for the TAU group (N=26). The TAU group was comprised of 
patients that completed inpatient integrated treatment program without the additional ACT 
treatment. Inclusion criteria for TAU mimicked the ACT group minus the ACT intervention.  
Results revealed that at 3- and 6-month follow-up the ACT group had 100% retention 
rates compared to the TAU group, which had 92% retention at 3 months and 84% retention at 6 
months. Patients in the ACT group reported longer abstinence at 3 and 6 months as well. 
Additionally, there were significantly lower Beck Depression Inventory (BDI) and Beck Anxiety 
Inventory (BAI) scores after 3 and 6 months and significantly lower Obsessive-Compulsive 
Drinking Scale (OCDS) scores in the ACT group. 
General counseling. Prior studies have found patients with dual diagnosis who were 
assigned to enhanced psychosocial groups had significantly more positive outcomes than patients 
with dual diagnosis who were assigned to standard psychosocial treatment group (SPS) group 
(Dugosh, 2016).  
In order to determine how to improve outcomes in individuals receiving buprenorphine or 
methadone maintenance treatment, Hesse and Pedersen (2008) conducted a quasi-experimental 
matched-sample study that compared the effectiveness of enhanced and standard psychosocial 
treatment. In the SPS group (n=177), dual diagnosis participants received case management 
along with MMT. In the enhanced psychosocial treatment group (EPS, n=126) dual diagnosis 
participants received case management, access to staff members, access to a drop-in center and 
MMT. There were several significant findings. EPS group had significantly more contact with 
treatment (P = 0.04) and missed fewer appointments (P < 0.0001) than the SPS group. The 
researchers also found that EPS group showed significantly higher social and psychiatric 
improvements (P’s < 0.05 and 0.01, respectively) than the SPS group. Inversely, the SPS group 
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showed significantly better financial improvements (determined through tax records) than EPS 
group. Neither group differed on self-reported alcohol or drug use.  
In another general support study on dual diagnosis patients, Gu et al. (2013) compared a 
basic MMT only (n=146) group to a MMT plus group, which consisted of standard MMT plus a 
behavioral maintenance therapy-based psychosocial intervention (n=142). Control group (MMT 
only participants) received a 5–15-minute orientation their first day, which provided them with 
program guidelines and services. No counseling services were provided, nor were they provided 
for the duration of the study. With aims to enhance therapeutic expectation, self-efficacy of 
maintenance, and satisfaction of therapeutic experiences associated with health-related outcomes 
(i.e. therapeutic alliance), and to increase family support, the experimental group (MMT plus) 
were provided twenty 30-minute counseling sessions by social workers. Results revealed that 
participants in the MMT plus group showed significantly more days of attendance of MMT 
during the study and were less likely to drop out of treatment (P’s < 0.001).   
Although the primary studied variables did not produce significant results, it appears that 
additional support in general does aid in MMT attendance. However, psychiatric needs were not 
addressed or met.   
Supportive-Expressive. Prior studies have found patients with dual diagnosis who were 
assigned to supportive-expressive psychotherapy plus substance abuse counseling showed no 
significant differences during the course of treatment over those patients receiving substance 
abuse counseling only. However, follow-up measurements at the 6-month mark revealed 
significant gains by the supportive-expressive psychotherapy plus substance abuse counseling 
group, while the 6-month follow-up measures revealed losses by the substance abuse counseling 
only group.  
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Woody et al. (1995) designed a study to determine whether professional psychotherapy, 
namely supportive-expressive psychotherapy, would appeal to patients at community-based 
methadone clinics, and whether it would be an effective approach. The study used 84 opiate-
dependent volunteers with moderate to high levels of psychiatric symptoms from three different 
community-based methadone treatment centers. The volunteers were randomly assigned to either 
supportive-expressive psychotherapy plus drug counseling (N=57) or drug counseling only 
(N=27). The average age of participants was 41 (SD=7):  40% were women; 57% were African 
American, and the remaining participants were white.  All treatment was provided weekly for 24 
weeks. After treatment ended, follow-ups were done at 1 and 6 months, during which outcomes 
were measured based on the Addiction Severity Index scoring scale that includes 20 different 
measurable domains. Urinalysis were given weekly to all participants for active treatment 
outcome measurements. 
There were no significant opiate-positive urine sample differences between groups. 
However, participants in the supportive-expressive psychotherapy plus drug counseling group 
had fewer cocaine-positive urine samples and required lower doses of methadone. At the 1-
month follow-up, after extra treatment ended, both groups showed significant gains but there 
were no significant differences between groups. At the 6-month follow-up, based on the 
Addiction Severity Index scores, gains made by the supportive-expressive psychotherapy plus 
drug counseling group remained while gains made by the drug counseling only group had 
diminished. More specifically, of the 20 indices included in the addiction severity scores 
measured between the 1- and 6-month mark following the end of treatment, the supportive-
expressive psychotherapy group showed improvement in 11, no change in 5, and worsening in 4, 
as compared to the drug counseling group that only showed 4 improved indices, no change in 1, 
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and a regression in 15. Although there were no significant differences shown during the study, it 
appears that the addition of supportive-expressive psychotherapy fosters sustained improvements 
and produces superior long-term results compared to the drug counseling only group.  
Crits-Christoph et al. (1999) conducted another study utilizing supportive-expressive 
psychotherapy in addition to drug counseling to measure the effectiveness of psychosocial 
treatments for cocaine dependence. The study measured four groups: individual drug counseling 
plus group drug counseling (GDC), cognitive therapy plus GDC, supportive-expressive therapy 
plus GDC, or GDC alone. Treatment included 36 individual sessions and 24 group sessions over 
6 months. Patients were assessed monthly during treatment and additionally at 9 and 12 months 
from baseline.  The principal outcome measures used were number of days of cocaine use per 
month and the drug use composite score from the Addiction Severity Index.  
The results revealed that although comparable overall, the individual drug counseling 
plus GDC showed significantly greater improvement on the Addiction Severity Index composite 
score and number of days of cocaine use than the two psychotherapies:  supportive-expressive 
therapy plus GDC and cognitive therapy plus GDC.  However, Crits-Cristoph et al. (2008) used 
data from the same study, the 1999 National Institute on Drug Abuse Collaborative Cocaine 
Treatment Study, to look more specifically at the outcomes of the patients who received 
supportive-expressive psychotherapy plus group drug counseling (GDC). While it was not the 
most efficacious treatment while the study was active, results were comparable with the other 
approaches and mean drug use scores were metrically lower at all follow-up assessments of 9, 
12, 15, and 18 months. More importantly, Crits-Christoph et al. (2008) found evidence that 
patients receiving supportive-expressive psychotherapy plus GDC were superior to individual 
drug counseling plus GDC regarding positive change in family/social problems at the 12-month 
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follow-up assessment, which, as previously mentioned, is a well-known protective factor for 
both drug abuse and mental illness.  
Collectively, these studies (Woody et al., 1995; Crits-Christoph et al., 2008) imply 
promising long-term outcomes by adding supportive-expressive psychotherapy to drug 
counseling, and protective factors that further suggest a more successful trajectory for overall 
recovery.  
Overview of Psychiatric Emergency Services (PES) in the United States  
There is great mental illness diversity amongst those that utilize PES. Prior studies have 
shown that high rates of PES use are associated with patients that are diagnosed with Bipolar 
Disorder, Schizophrenia (Baillargeon et al., 2008), Major Depressive Disorder (Himelhoch, 
Weller, Wu, Anderson, & Cooper, 2004; Johnson, Weissman, & Klerman, 1992), General 
Anxiety Disorder (Himelhoch et al., 2004), Posttraumatic Stress Disorder (Onoye et al., 2013), 
and Substance Use Disorder (Bai, Lin, Hu, & Yeh, 1998; Vu et al., 2015).   
Additionally, co-occurrence with substance use is excessive. In 2012, researchers 
conducted a national study of PES use in the Veteran’s Health Administration (VHA) and found 
that substance abuse disorders and psychiatric disorders were highly correlated in PES (Doran, 
Raven, & Rosenheck, 2013).  Although it has been generally established that patients with dual 
diagnosis use PES more frequently than those without dual diagnosis (Haywood et al., 1995; 
Hoff & Rosenheck, 1999), there has been minimal research done regarding how to approach the 
problem of dual diagnosis patients overusing PES (Curran et al., 2003). According to policy 
proposals, assertive community treatment, and case management, VHA suggested improved 
access to outpatient services, which may be potentially a vital component to decreases PES 
usage. 
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Additionally, previous research reported a continued and rapid increase in PES due to 
ongoing diminished rates of institutionalization, reduced availability of hospital beds, shortage of 
financial resources, and decreased duration of hospital stays for psychiatric purposes (Brasch & 
Ferencz, 1999; Currier, 2000; Pasic, Russo, & Roy-Byrne, 2005). For patients with chronic 
mental illness, PES are where the majority enter into the mental health system (Allen, 1996; 
Gerson & Bassuk, 1980). Patients that utilize these services typically present with psychosis, 
substance use disorders, depression, or Axis II disorders, with substance abuse identified as the 
primary cause of PES utilization (Lukens et al., 2006). 
As previously stated, PES have been used as a default source of treatment for this 
population.  An emerging increase in patient volume, the complexities of patients’ emergency 
presentations, and decreased inpatient care led Gerson and Bassuk (1980) to present the concept 
and first model of PES.  Their model essentially consisted of walk-in crisis services staffed by 
non-health professionals (Curran et al., 2003; Currier & Allen, 2003; McIlwrick & Lockyer, 
2011).  According to Currier (2000), the attending patients were often sent to emergency rooms 
where staff triaged them to crisis workers that had very little access to mental health training. 
The main focus of these earlier PES was simple crisis intervention with inadequate referrals, and 
did not involve thorough assessment or psychopharmaceutical treatment. Recognizing this 
problem, Gerson and Bassuk (1980) introduced more comprehensive models that have 
necessitated the triage model, providing a broader range of services with comprehensive 
assessment (Allen, 1996).  Existing PES provide diagnosis, psychopharmaceuticals, treatment, 
psychotherapy, follow-up visits, resource allocation, and referrals to applicable community 
services (Currier & Allen, 2003; Gerson & Bassuk, 1980; McIlwrick & Lockyer, 2011).  
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In most cases, PES are open 24 hours a day, 7 days a week, and have a psychiatrist on 
site at least 8 hours daily. According to a meta-analysis conducted by (Currier & Allen, 2003), 
psychiatrists are responsible for the preliminary medical evaluation and medical clearance at 
55% of psychiatric emergency sites after the triage process. Pharmacological therapy is regularly 
initiated in patients being admitted and released. Currier and Allen (2003) also report that the 
average stay is approximately 9 hours. Depending on their condition and available referrals, 
patients often remain overnight. Referrals to aftercare and options for substance abuse care are 
also allocated during the patients’ visits, as well as follow-up visits.  Unfortunately, the research 
reveals insufficient referral opportunities for substance use— the primary cause of recidivism for 
PES care (Pasic et al., 2005; Pines et al., 2011). 
There is a continuous upsurge of individuals using PES (Larkin, Claassen, Emond, 
Pelletier, & Camargo, 2005; Pines et al., 2011; Salinsky & Loftis, 2007).  However, PES have 
not been a sufficiently studied component of community mental health systems (Lincoln et al., 
2016). To date, there has been only minimal research done on why people repeatedly utilize 
these services. In fact, Lincoln et al. (2016) state that there have been no studies wherein repeat 
users were asked about their experiences with PES or why they were seeking it. Therefore, 
Lincoln et al. (2016) conducted a Community-Based Participatory Research (CBPR) to identify 
why individuals access PES and what their experiences were. CBPR is defined as a scientific 
investigation conducted collaboratively that engages affected community members in every 
aspect of the study (Viswanathan et al., 2004). Essentially, the CBPR is driven by the 
community, where those community members’ needs are specifically heard and, hopefully, met 
(Israel et al., 2003). Overall, the findings were mixed. Results are discussed in more detail in the 
following section. 
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PES and Patients with Dual Diagnosis 
There is a common theme amongst the majority of the frequent PES users:  the 
contributing factors are often associated with both substance abuse and psychiatric issues 
(Andrén & Rosenqvist, 1985; 1987). Because there are very few integrative options for this 
population, beyond inpatient substance abuse treatment centers, the symptoms of dual diagnosis 
frequently go untreated and the trajectory of the condition is not halted until the symptoms are 
acute. At which point, neither the public health nor the mental health clinician is adequately 
prepared to provide care. Unfortunately, interventions do not happen until symptoms are acute, 
and the dual diagnosis patient is left in crisis. Consequently, PES has become an alternate 
treatment option for this population (Wolfe & Sorensen, 1989).  
This population is also burdened by homelessness (Olfson et al., 1999), violence (Soyka, 
2000), suicide (Soyka et al., 2002), incarceration (McNiel et al., 2005), and an increased risk for 
HIV and hepatitis (Hoff & Rosenheck, 1999).  Considering the association of mental health 
disorders and substance use disorders with frequent PES visits (Baillargeon et al., 2008; 
McGeary & French, 2000), there may be a positive correlation between frequent use of PES and 
dual diagnosis, providing another compelling reason to treat both opioid use disorder and MI in 
patients with dual diagnoses. 
In one cross-sectional study, Vu et al. (2015) found that patients with higher rates of 
substance use disorders and mental health disorders were more likely to be a frequent user of 
PES than patients who had lower rates of substance use disorders and mental health disorders. 
The study found that 31% of those with mental disorders were frequent PES users as compared 
to 22% of those without a mental disorder. Additionally, the study found that 10% of participants 
with a substance use disorder were frequent PES users as compared to 6% of those without.  
Lastly, the study found that 25% of the participants that had both a mental disorder and a 
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substance use disorder were frequent PES users as compared to 8 % of those who did not have 
either. However, it appeared that physicians under-diagnosed participants across both groups—
frequent and non-frequent PES users. Additionally, PES patients that screened positively for 
psychiatric disorders and substance abuse disorders were more likely to be a frequent user of 
PES than patients with no diagnosed disorder. The researchers also found that there were higher 
proportions of patients with substance use disorders and mental health disorders compared to 
proportions of the patients attending mainstream emergency rooms (no disorder: 35% vs. 67%; 
mental health disorders only: 31% vs. 22%; substance use disorders only: 10% vs. 6%; both 
mental health and substance use disorders: 25% vs. 8%.). 
Concerning whether frequent use of PES can be predicted by mental health disorders or 
substance abuse disorders, the study found that patients who screened positively for either a 
mental health disorder or a mental health disorder and substance use disorder were at a higher 
risk of being classified as a frequent user (4 visits or more over a 12-month period of time), 
compared to patients without a diagnosed disorder. These findings are consistent with previous 
studies that show those with mental health issues and substance use issues could hypothetically 
be associated with the convenience and accessibility of PES (Baillargeon et al., 2008; McGeary 
& French, 2000), especially among uninsured patients (Baillargeon et al., 2008).  
In their CBPR, Lincoln et al. (2016) found that in all but one interview, substance abuse 
was discussed. Many participants reported that they were seeking PES because they 
inadvertently discontinued their prescribed medications and consequently used alcohol or other 
substances, which eventually exacerbated their mental illness (two-thirds of the respondents 
reported that their medication regimens had been compromised prior to admitting themselves to 
PES). Over half of these individuals reported that they were unable to afford copayment for their 
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medications or could not afford insurance at all. The participants complained that in seeking 
PES, they found that they were over-identified with their substance abuse and were often simply 
placed in a detox. Participants commonly reported that they were not interested in repeated 
detoxifications but rather wanted assistance and treatment with and for their mental illness 
symptoms. Ultimately, many reported that they would like to have access to more dual diagnosis 
programs. For those who were not familiar with the term dual diagnosis, they reported they 
would like to engage in treatment that addressed both their psychiatric issues and their substance 
abuse issues (Lincoln et al., 2016). This is important to acknowledge. Clearly, we have eager 
individuals that want therapy that treats the whole individual. 
Overall findings suggest that screening for substance use and mental health disorders 
warrants a plan of intervention that considers the overrepresentation of dual diagnoses in the PES 
(Vu et al., 2015). Future research determining the feasibility and appropriateness of screening for 
mental health and substance use disorders (Vu et al., 2015) is warranted. Additionally, improving 
access to outpatient services may be a vital component in decreasing PES usage among frequent 
users with dual diagnosis.  
Consequences of Frequent Use of PES on United States’ Healthcare System and Economy 
Due to the higher proportions of substance abuse use disorders and mental health 
disorders utilizing PES, frequent users have become of special interest to researchers as 
compared to mainstream emergency room users (Bieler et al., 2012; Fuda & Immekus, 2006; 
Williams et al., 2001).  Bieler and colleagues define frequent users as adult patients that utilize 
PES 4 or more times in a 12-month period. As previously stated, individuals with dual diagnosis 
present an assortment of problematic issues such as violence, homelessness, arrest, and suicide 
(Cornelius et al., 1995). According to the literature, the abuse of substances accelerates the 
psychiatric symptoms from which this population already suffers.  Because substance abuse 
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exacerbates the symptoms, these individuals are often left in crisis (McCarrick, Manderscheid, & 
Bertolucci, 1985) and, commonly, enter the mental health system through PES (Elangovan et al., 
1993).  
There is a wide range of problems related to those who frequent PES, including increased 
rates of mortality and morbidity. Many healthcare stakeholders such as providers, payers, 
employers and consumers find this troubling (Hansagi, Edhag, & Allebeck, 1991).  For instance, 
since frequent PES users are not being appropriately accommodated with services to treat the 
duality of their diagnosis, they continue to loop back through the services and often worsening 
their condition by increasing crime involvement (Degenhardt et al., 2014), homelessness, 
healthcare costs (Black, Trudeau, Cassidy, Budman, & Butler, 2012) and lessening service 
productivity because of overcrowded waiting rooms (Weiss et al., 2012).   
In 2015, The Healthcare Cost and Utilization Project (HCUP) reported that aggregate 
costs in the United States for inpatient visits for dual diagnosis patients utilizing PES reached an 
astounding 11 billion dollars. Further, HCUP notes that the average stay was more than 38% 
higher for dual diagnosis patients as compared to all other patients and that Medicaid was the 
most common payer for dual diagnosis visits, at 30.9% (Heslin, Elixhauser, & Steiner, 2015). 
Additionally, these frequent users typically have fewer social resources, are of lower 
socioeconomic status, and much more socially isolated (Andrén & Rosenqvist, 1985; Spillane et 
al., 1997), often resulting in treatment compliance barriers and the aforementioned unfavorable 
outcomes (Curran et al., 2003). According to health policy, health services, and economic 
perspectives, there are small subclasses of repeat patients that utilize a disproportionate amount 
of PES (Malone, 1995). Consequently, there is an evolving body of multidisciplinary research 
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that seeks solutions and interventions to improve patient care and decrease the use of PES 
(Curran et al., 2003).  
Bay Area Addiction and Research Treatment (BAART): An Integrated Clinical Model 
Introduction of mental health services to BAART. As described previously, the 
California state legislature passed Assembly Bill 2071 (AB2071) in 1997, which instructed that 
methadone clinics were required to provide at least 50 minutes of SAC each month to their 
patients. Prior to the passage of this bill, methadone clinics were only required to provide two 
SAC sessions per month, with a 15-minute session minimum (Kletter, 2003). Kletter (2003) 
recognized severe cocaine issues among patients at BAART, a methadone clinic in the 
Tenderloin District of San Francisco. Given the recent mandated counseling implementation and 
the cocaine problem amongst the patients at BAART, Kletter (2003) decided to conduct a study 
measuring cocaine use differences at baseline and after mandated counseling among patients 
who were in the electronic database conserved at BAART. 
In the study, 179 cocaine-abusing patients were examined using a pretest-intervention-
posttest design. Cocaine use was measured via urinalysis, which was recorded in the electronic 
database. Counseling time was extracted accordingly. Baseline study outcomes were measured 
12 months prior to AB2071 and posttest measurements were taken 2 years after mandated 
counseling.  The researcher found that there was a decrease in cocaine use after AB2071 was 
passed. Additionally, the amount of counseling time was negatively correlated (r=-22, p=.0431) 
with heroin use; that is, the more counseling the patients received, the less positive urinalysis for 
cocaine they produced (Kletter, 2003).  
In 2010, BAART added another counseling modality to their program, MHC, which has 
not been investigated to date. Therefore, the present study examined BAART’s latest mental 
health program, an integrated treatment model. 
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Description of BAART model. BAART is not only a methadone clinic but also a 
primary care practice. Many patients receive their medical maintenance treatment (MMT), 
psychiatric treatment, and medical services at BAART, making BAART a community-based 
integrated behavioral health medical center. When a patient comes to BAART for methadone 
maintenance, the stabilized or effective maintenance dosage is found by titrating the patient 
upward until the withdrawals subside and the patient discovers a dose that is comfortable for 
them.  If the patient continues using opiates, the program may increase their dose. The maximum 
starting dose is 30 mg. Patients who miss 3 consecutive days of dosing will have their dose 
dropped by 10 mg and will be required to wait on an order from the doctor prior to future dosing. 
The clinic is open 7 days a week. Weekday dosing hours are from 7:00 am to 2:30 pm. The 
7:00–7:30 am timeslots are reserved only for patients with jobs. Weekend dosing hours are from 
8:00 am to 12:00 pm and holiday dosing hours are from 9:00 am to 12:00 pm. Maintenance 
patients may receive a take home dose on holidays if the program believes the patient can 
responsibly handle the take home and has a history of adhering to program rules.  
BAART has a 6-step take home policy for patients who are meeting particular 
requirements and deemed by their physician responsible enough to handle narcotic medication. 
Step 1 allows for the patient after 3 months of continuous program adherence to potentially 
receive one day of take homes a week. Step 2 allows for the patient after 6 months of continuous 
program adherence to receive two days of take homes a week. Step 3 allows for the patient after 
9 months of continuous program adherence to receive three take homes a week. Step 4 allows for 
the patient after one year of continuous program adherence to receive 4 take homes a week. Step 
5 allows for the patient after two years of continuous program adherence to receive 5 take homes 
a week. Step 6, the final step, allows for the patient after 3 years of continuous program 
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adherence to receive 6 take homes a week. Patients are given random urinalysis, typically once a 
month. Positive urinalysis for illicit drugs or negative results for methadone will be reviewed by 
staff and consequences may apply. For those with take homes, their step status may be reduced.  
As previously mentioned, methadone clinics in California are required to provide at least 
50 minutes of substance abuse counseling a month. However, patients at BAART are required to 
accumulate a minimum of 90 total minutes a month of SAC. They then have the option of mental 
health counseling to accommodate their psychiatric needs. Those that choose to use mental 
health counseling typically receive one 50-minute session a week in which the psychiatric needs 
are the sole focus, while the substance abuse needs are the sole focus of the 90 minutes of 
required time with their substance abuse counselor. Because BAART is an integrated behavioral 
health center and substance abuse counselors, mental health counselors, psychiatric, medical 
doctors, nurse practitioners, and psychiatric nurses are all under the same roof, collaboration 
between professions is the common approach. This model demonstrates practical sense and 
provides the patient with a team of providers all working together to afford the best possible 
outcome for the patient. However, this study focused specifically on the benefit of adding mental 
health counseling to the program. Most methadone clinics only provide substance abuse 
counseling because it is a legal requirement. However, as we have noticed throughout this 
review, the substance abusers most often have other psychiatric issues and are considered dually 
diagnosed.  BAART’s approach of coupling substance abuse counseling with mental health 
counseling answers the duality of their issues. Accordingly, this study confirmed that patients 
receiving MHC in addition to SAC show a significant decrease in PES utilization.  
Significance of Research Project for Clinical Psychology  
The first goal of the present study was to examine whether adding mental health services 
in addition to SAC services at a methadone clinic would have an impact on patients’ use of PES 
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services. This was the first study to examine the use of PES services among patients at a 
methadone clinic either receiving standard SAC-only treatment or receiving SAC and MHC 
treatment. Therefore, the effects of an integrative treatment approach at a methadone clinic were 
explored. Due to the multitude of complications and adversities that individuals that suffer from 
addiction and mental health illness are plagued with, and the high prevalence rates of PES 
services that they utilize, it is crucial for clinicians and institutions alike to fully understand how 
to affordably and effectively provide treatment. Furthermore, the health disparities that distance 
this population from more privileged populations is already overwhelming. In many cases, it is 
systemic oppression that contributes to the individuals’ deep states of distress in the first place. 
Therefore, as healthcare research fueled by the University of San Francisco’s Jesuit social justice 
mission to honor the welfare of every individual—regardless of SES, race, gender, or sexual 
orientation, with the data at hand, this study aims to expose, study, and correct the momentum 
that continues to separate them from the rest.  
This dual diagnosis population is influenced by many multiple impairing issues such as 
disease, opioid overdose, incarceration, homelessness, and death, among others but at a higher 
rate than substance abuse population or mental health illness population. Historically, PES has 
been most common place where this population is seen.  This trend is not only taking a toll on 
the economy, but PES is also not equipped to handle this population properly, often resulting in 
multiple repeat visits by the same patients. Therefore, creating another environment to treat this 
population is beneficial to the patients, hospitals, healthcare system, and economy.  
Patients in both groups were compared on the primary and secondary outcomes variables, 
the results of which can further provide information if the effects of an integrative treatment 
approach at a methadone clinic is beneficial to this dual diagnosis population. Archival data were 
EFFICACY OF INTEGRATED MENTAL HEALTH CARE 32 
 
used, as well as patients’ outcome variables and other information from 2014 to 2017. Patients 
who would have started before 2014 and/or ended before 2017 were excluded from the study. 
The following research questions were addressed in the present study: 
Main Research Questions 
Research Question 1: Do patients with dual diagnosis who are assigned to Substance 
Abuse Counseling (SAC) and Mental Health Counseling (MHC) differ in the mean number of 
Psychiatric Emergency Service (PES) visits from the patients with dual diagnosis who receive 
Substance Abuse Counseling (SAC) only between 2014 and 2017? 
Research Question 2: Do females and males differ in the mean number of Psychiatric 
Emergency Service (PES) visits between 2014 and 2017? 
Research Question 3: Does age positively or negatively correlate with the number of 
Psychiatric Emergency Services (PES) visits between 2014 and 2017? 
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Chapter III: Methods 
Design 
Using archival data, this program evaluation is designed to assess whether dual diagnosis 
patients at a methadone clinic who received voluntary MHC in conjunction with SAC between 
the years 2014 and 2017 utilized PES more times or less times than those who received SAC 
only.   
MHC is comprised of weekly 50-minute psychotherapy sessions with a mental health 
counselor that aims at exploring and resolving psychological ailments applying theories such as 
Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), Dialectical 
Behavioral Therapy (DBT), Motivational Interviewing (MI), and Motivational Enhancement 
Therapy. SAC involves meeting with a substance abuse counselor weekly to monitor substance 
use and aspects of recovery, such as encouraging 12-step membership, monitoring abstinence, or 
assisting in harm reduction.  
The setting is Bay Area Addiction Research Treatment (BAART), an Integrated 
Behavioral Health Medical Methadone clinic in the Tenderloin District of San Francisco, 
California.  The differences between groups were measured using secondary/archival data from 
electronic databases used by BAART to store patient records. 
Participants 
There were 34 (50.7%) patients with dual diagnosis who received SAC and MHC, and 
there were 29 (43.3%) patients with dual diagnosis who received SAC only between 2014 and 
2017 from BAART archival electronic records. A total of 67 persons were randomly selected 
from the electronic database. Of these, four participants (6.0%) were dropped because they had 
missing data. The final sample of 63 participants (94.0% of the 67 patients who had data ) 
consisted of those who had sufficient data on at least demographic variables to provide 
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descriptive statistics for the sample. Data were missing for 2 participants from each treatment 
group, All analyses were performed separately for SAC only and SAC and MHC groups.  
G-Power was used to determine the number of participants per group needed for all 
analyses in order to have minimal power of 0.80. The majority of participants were of low 
socioeconomic status. Inclusion criteria for all participants included: at least one mental illness 
diagnosis, Opioid use disorder, methadone medical treatment (MMT), and SAC. MHC is the 
additional qualification for the experimental group.  Because this population often presents under 
the influence of illicit drugs during evaluation, and the long-term side effects of substance use 
that resemble neurological disorders, neurological disorders are often misdiagnosed. Therefore, 
patients with neurological disorders were excluded from the study. Patients who started receiving 
any services prior to 2014 and/or finished services before 2017 were also excluded.  
Participants’ data from 2014 to 2017 was collected from Avatar and Methasoft. 
Methasoft is the electronic database used by substance abuse counselors, whereas Avatar is the 
electronic database that the mental health counselors use. 
“Avatar is a certified electronic health record (EHR) solution specifically designed for 
behavioral healthcare and addiction treatment in community-based, residential, and in-patient 
programs (Avatar, 2017).” BAART uses Avatar to record and store all patient information. “It 
offers a robust set of features that support roles throughout the organization, from front desk staff 
and clinicians to billing administrators and executive management (Avatar, 2017).”  Applicable 
data such as diagnosis, mental health counseling notes, and PES episodes are stored in Avatar.  If 
a patient at BAART utilized PES anywhere in San Francisco County, it was recorded into 
Avatar.  
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“The Methasoft Treatment Management System is a cutting-edge clinical, computerized 
software designed particularly for opiate addiction treatment facilities. Methasoft aids in 
improving communication, increasing accountability, greater efficiency and enhancing reporting 
within all areas of a methadone clinic (Methasoft, 2017).” Modules for Methasoft include 
Financial Management, Pharmacy Management, Patient Management, and Clinic Management. 
Additional data, collected through Methasoft, might include: employment, marital status, 
type/status of the insurance, housing situation, age, ethnicity, SAC units serviced (1 unit is 10 
minutes of SAC), methadone dosing frequency, case notes, and urinalysis results. Substances 
screened for in urinalysis include: methadone, methadone metabolite, 6 acetylmorphine, 
amphetamine, methamphetamine, barbiturates, cocaine, hydromorphone, hydrocodone, codeine, 
morphine, benzodiazepines, and oxycodone (Methasoft, 2017). At BAART, patients are 
randomly tested approximately once a month.  
For patients with dual diagnosis who received SAC and MHC, there were 19 males 
(52.7%) and 15 females (41.6.%). The mean age of this group of patients was 49.91 years (SD = 
11.10). The mean number of PES episodes for this group was 0.44 years (SD = 0.84). Finally, 
this group of patients received mean number of 544.66 (SD = 106.35) SAC units, which was 
77.42 (SD = 36.50) hours. 
For patients with dual diagnosis who received SAC only, there were 15 males (48.4%) 
and 14 females (45.16%). The mean age of this group of patients was 54.16 years (SD = 12.82). 
The mean number of PES episodes for this group was 1.48 years (SD = .3.42). Finally, this group 
of patients received mean number of 449.87 (SD = 117.66) SAC units, which was 84.83 (SD = 
54.99) hours. 
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Materials 
Psychiatric Emergency Service (PES). PES provides psychiatric evaluation, 
intervention and referral for both voluntary and involuntary patients 24 hours a day, 7 days week.  
When a patient visits PES anywhere in the county of San Francisco, each PES episode/visit is 
recorded into Avatar. A PES episode/visit is defined as any emergency psychiatric care a patient 
receives within the county where the patient resides. The researcher used Avatar to calculate 
total number of PES visits utilized by both groups between 2014 and 2017. Patients who 
received treatment outside of the dates examined in the study were excluded. 
Substance Abuse Counseling (SAC) sessions.  Patients receive SAC weekly. The length 
of SAC sessions varies. The time is measured in units and patients are required to attain 9 units 
each month, and each unit equals 10 minutes of duration. SAC sessions accrued between 2014 
and 2017 were taken from Methasoft’s Data Assessment and Plan (DAP) notes. Each substance 
abuse counselor entered the number of units rendered per service into Methasoft, along with their 
DAP notes each week.  
Procedure 
The control group (n=29) consisted of dual diagnosis participants receiving SAC only 
from 2014 to 2017. The experimental group (n=34) consisted of dual diagnosis patients receiving 
SAC plus MHC from 2014 to 2017. The time period for the SAC group was from 7/1/14 to 
7/1/17. However, the time period for MHC and SAC group varied starting with different years 
and ending with different years. In order to compare groups on all outcomes and avoid 
confounding variables, participants who started in 2014 and ended in 2017 were included, and 
others were excluded from all analyses. All participants in this study were methadone patients, 
divided into two groups: MHC+SAC group and SAC-only group. Because Methasoft is the 
database for the methadone patients, the investigator used Methasoft to extract all group 
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members. Random number generator table was used to randomly select the participants from the 
database. Then, selected participants were placed into Avatar to see if they were receiving mental 
health services at BAART. If they were, 34 participants were randomly assigned through random 
number generator chart to the experimental group (SAC+MHC). If they were not, then 31 
participants were randomly assigned through random number generator chart to the control 
group (SAC only). 
Once the groups were determined, the investigator copied and pasted participant names 
into AVATAR to identify and calculate their PES episodes from 2014 to 2017. An episode is 
defined as any emergency psychiatric care a patient receives within the county where the patient 
resides. For example, if a patient at BAART accessed psychiatric care of any variety (i.e., 
general counseling, dual diagnosis substance abuse programs, or PES anywhere in San Francisco 
County), it was recorded and stored within the Avatar database.  PES episodes included any 
visits to Westside Crisis, Progress Foundation, Dore Street Clinic, Psyche Emergency Services, 
Crisis Response Team, Mobile Crisis, San Francisco General Hospital, Conversion Program, 
Crisis Stabilization, Psyche Emergency, Avenues Crisis, Shrader House Crisis, La Posada, and 
St. Francis Hospital Psyche Emergency. Patients in both groups were compared on the number of 
PES episodes/visits between 2014 and 2017, so those who started services before 2014 were 
excluded. 
Sessions accrued for the MHC group between 2014 and 2017 were extracted from the 
client service report stored in Avatar. SAC sessions (1 unit = 10 minutes of SAC) accrued in 
2014–2017 were taken from Methasoft’s Data Assessment and Plan (DAP) notes. Each 
substance abuse counselor entered the number of units (1 unit = 10 minutes of SAC) rendered 
per service into Methasoft along with their DAP notes.  
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Demographic variables, such as age, gender, ethnicity, socioeconomic status, psychiatric 
diagnosis(es), relationship status, and housing were extracted and descriptive statistics were 
reported. Moreover, males and females were compared in their use of PES visits. Finally, the 
study examined if there was a relationship between age and number of PES visits. This 
additional information might provide answers to unexpected findings. 
Purpose 
As the literature review reveals, this population suffers an extensive profile of detrimental 
consequences. There are systemic determinants that put many of these individuals in this 
position, including oppression, discrimination, and limited access to resources. Methadone 
clinics offer an ideal and rare opportunity to treat this population holistically. Further, as the 
drive to improve mental health services continues, this study provided a prime opportunity to 
investigate whether the integrative treatment approach of MHC & SAC is more successful in the 
quest to avoid crisis situations for this vulnerable population.  
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Chapter IV: Evaluation/Analytic Plan and Results 
Preliminary Analyses 
Statistical Software SPSS 22 was used to obtain descriptive characteristics, as well as to 
conduct statistical analyses to answer Research Questions 1–3. Demographic data were limited 
to gender and age because those were the only consistently collected data available (see Table 1). 
Had we included only participants that had all their descriptive data available, the sample size 
would have been too small for a robust statistical analysis.  
Table 1 
Demographic Data 
Group 
Age Males Females 
M (SD) n (%) n (%) 
SAC and MHC 
SAC only 
49.91 (11.10) 
54.16 (12.82) 
19 (52.7%) 
15 (48.4%) 
15 (41.6%) 
14 (45.16%) 
 
Evaluation of Parametric Assumptions and Conceptual Plan 
Parametric assumptions, such as normality, linearity, and homoscedasticity, were 
evaluated prior to conducting Pearson correlation analyses. The assumption of homogeneity of 
variance, in addition to normality, was evaluated prior to conducting independent samples t-tests. 
Normality was evaluated through consideration of descriptive statistics, visual inspection of 
score distributions, and computations of normality statistics. The normality assumption clearly 
was violated for all studied variables with the exception of SAC units in hours, which 
approached a normal distribution.  
Linearity was evaluated through visual inspection of bivariate scatterplots. This 
assumption was violated. The assumption of homoscedasticity was evaluated through visual 
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inspection of regression plots relating standardized predicted values to standardized residuals. 
This assumption was violated as well.   
Although the assumption of normality is not critical in Pearson correlations (Havlicek & 
Peterson, 1977), violation of the assumption of linearity for certain pairs of variables was a 
concern. To gauge the impact of violation of these assumptions on correlational results, Pearson 
and Spearman correlations were both run when bivariate correlation analyses were called for, 
and results were compared. Obtained results were very similar. Consequently, Pearson 
correlations are presented for all correlation analyses.  
Independent samples t-tests and Mann-Whitney U tests were run to analyze gender 
differences on the studied variables. The homogeneity of variance assumption, evaluated through 
Levene’s test, was not met, and bootstrapping was used when possible. Results obtained with the 
U tests were very similar to those obtained with the t-tests. Consequently, independent samples t-
tests were used for analyses of differences between the studied groups.  
Tests of Hypotheses 
Analyses of means. Research Question 1 asked if patients with dual diagnosis who 
received SAC differed in the mean number of PES visits from the patients with dual diagnosis 
who received SAC and MHC between 2014 and 2017. Patients with dual diagnosis who received 
SAC (M = 1.48, SD = 3.42) reported higher number of PES visits than patients with dual 
diagnosis who received SAC and MHC (M = 0.44, SD = 0.84), t = -16, df =59, p = .02, 95% CI [-
2.29, 0.20].  
Research Question 2 asked if females differed in the mean number of PES visits from 
males between 2014 and 2017.  For both treatment groups combined together, there was no 
significant gender difference found in mean PES visits between males (M = 0.86, SD = 1.90) and 
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females (M = 0.31, SD = 0.74), t = 1.391, df = 53, p = .169, Service, 95% CI [-0.01, 1.35], based 
on 1000 bootstrap samples.    
Associations among age and drug-related variables. Research Question 3 asked if there 
were significant correlations between age and the number of PES visits between 2014 and 2017 
among patients who received SAC and patients who received SAC and MHC. For patients who 
received SAC, there was no significant association between age and the number of PES visits, r 
= .18, p = .331 (Figure 1). For patients who received SAC and MHC, there was no significant 
association between age and the number of PES visits, r = -.12, p = .541 (Figure 2).  For both 
treatment groups combined, there was no significant association between age and the number of 
PES visits, r = - 0.01, p = .958 (Figure 3).  
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Figure 1. Bivariate scatterplot of PES and age, for SAC-only group. 
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Figure 2. Bivariate scatterplot of PES and age, for SAC & MHS group. 
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Figure 3. Bivariate scatterplot of PES and age, for both groups combined. 
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Chapter V: Discussion 
The present study aimed to contribute to the existing research by exploring a more 
effective treatment model for individuals with dual diagnoses at methadone clinics. The 
objective was to determine whether or not individuals with dual diagnosis receiving integrative 
care (MHC and SAC, specifically those with an opioid disorder and a mental illness) at a 
methadone clinic accessed PES less than individuals who were receiving SAC alone. Differences 
in PES utilization between females and males from both treatment groups were also measured, as 
were correlates of age and number of PES visits of both groups.  
The results indicate that individuals with dual diagnosis at a methadone clinic, who are 
receiving both SAC and MHC, access PES significantly less than those who are receiving SAC 
only. These findings suggest that those who suffer from dual diagnosis benefit from an 
integrative health care model. Furthermore, these individuals can potentially avoid unfavorable 
outcomes when both their substance use and mental health issues are addressed.  
SAC Only Versus SAC and MHC 
Research question 1 asked if patients with dual diagnosis who received SAC differed in 
the mean number of PES visits from patients with dual diagnosis who received SAC and MHC 
between 2014 and 2017. The results revealed that the SAC group’s mean score of 1.48 PES visits 
was significantly higher than the SAC plus MHC group’s mean score of .44 PES visits. These 
findings suggest that SAC plus MHC is a more effective treatment modality for patients with 
dual diagnosis at a methadone clinic than SAC only. These findings will be discussed in further 
detail below. 
Females Versus Males  
Research Question 2 asked if dually diagnosed females differed in the mean number of 
PES visits from dually diagnosed males between 2014 and 2017.  The results revealed that for 
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both treatment groups combined, although not significant, the males’ mean score of .86 
psychiatric emergency services visits was higher than the females’ mean score of .31 psychiatric 
emergency service visits. These findings indicate that, in general, males with dual diagnosis have 
a higher probability of accessing psychiatric emergency services. There is a paucity of literature 
addressing the main questions of this study. A review of the literature does not reveal other 
studies specifically examining gender differences in PES utilization for dual diagnosis patients, 
so there is no existing empirical data to explain the trend discovered toward greater PES use by 
males. However, we speculate that females may utilize more protective factors (such as social 
support) than males, while we also speculate that males may be engaging in more risky behaviors 
that increase the need for PES. These psychosocial factors may contribute to the trend found in 
this study. 
Age Correlation  
Research question 3 asked if there were significant correlations between age and the 
number of PES visits between 2014 and 2017 among patients who received SAC and patients 
who received SAC and MHC. The results revealed that there was no correlation with age. As 
noted above, due to the paucity of studies in this general area of concern, there are no studies that 
this author was able to find that directly looked at the variable of age in relation to dual diagnosis 
patients’ utilization of PES. Given that, I can only speculate on the findings of this study in 
relation to this question. In broad terms, I speculate that there are many different reasons at 
various ages that this population requires PES, as they appear to be susceptible to emergency 
situations in general throughout the course of their affliction—regardless of age. It is likely that 
in the absence of impactful treatment that produces enduring effects, this population continues to 
overutilize PES services throughout their lifespan. 
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The results confirm the hypothesis that individuals with dual diagnosis at a methadone 
clinic, who are receiving both SAC and MHC, access PES significantly less than those who are 
receiving SAC only, indicating that those who suffer from dual diagnosis benefit from an 
integrative health care model. Further, although not significant, results indicated a trend 
suggesting that males access PES more than females. Lastly, results revealed that there is no 
significant correlation between age and number of PES visits among patients who received SAC 
and patients who received SAC and MHC. 
Clinical Implications 
Clinical Competence and Training  
In general, our results indicate that employing an integrative approach is effective with all 
individuals with dual diagnosis. This treatment could provide the answer to a long-standing 
problem. Drake, Mueser, Brunette, and McHugo (2004), Mangrum, Spence, and Lopez (2006), 
and Mueser (2003) have all indicated an appropriate and respectful treatment for those with dual 
diagnosis would be an integrated approach, which addresses both the substance use disorder 
(SUD) and mental illness (MI) as primary disorders. Hansen and colleagues (2000) report that 
one of the reasons for mistreatment and lack of respect among this population is physicians’ 
difficulties in differentiating between the symptoms of MI and SUD, causing feelings of clinical 
incompetence, and often resulting in negative treatment of patients. Consequently, appropriate 
treatment is not provided. Using the integrative approach negates the differentiation problem, as 
it is designed to address both diagnoses from the beginning. Additionally, as physicians are 
armed with a model that provides them with an appropriate treatment model with which to 
effectively treat this population, one would expect physicians to treat the dually diagnosed with 
more respect, ultimately decreasing the stigma, increasing treatment retention and compliance, 
and, consequently, improving overall outcomes among this population.   
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Healthcare Costs 
These findings provide a simple solution to a deep-rooted, persistent challenge. 
Clinicians and physicians alike have been baffled for decades about how to treat this population, 
so much so that many care providers ultimately turn their back on them. Additionally, PES has 
become an alternative and costly source of treatment for individuals with dual diagnosis, as they 
are unable to find proper treatment elsewhere. When they are unable to find appropriate 
treatment, their symptoms increase to the point that emergency services are ultimately required. 
There are myriad problems with using PES, or emergency services in general. These problems 
can be prevented with the development of clinics that properly accommodate this population. 
There are astronomical costs associated with routine access of PES. Healthcare Cost and 
Utilization Project (HCUP) reported that in 2015, there were $11 billion of aggregate costs for 
inpatient visits for dual diagnosis patients utilizing PES in the United States. Additionally, 
HCUP noted that patients with dual diagnosis stay at PES 38% longer than all other patients 
(Heslin, Elixhauser, & Steiner, 2015). A decrease of merely 20% would lessen costs by 
approximately $3.67 billion. This issue not only affects the overall cost of health insurance, but 
also supports the stigma that this population is problematic given these associated costs. The 
stigma alone can deter this population from seeking services until it is an emergency, when they 
once again find themselves accessing services that are costly and ineffective. In no uncertain 
terms, the underlying problem of dual diagnosis patients accessing PES is not effectively being 
addressed on a macro level.  
As noted, healthcare costs associated with patients with dual diagnosis accessing PES are 
exceedingly high. However, these costs do not even include the collateral costs associated with 
other healthcare problems or the consequences of risky behavior associated with substance 
abuse. As previously mentioned, this population is burdened with homelessness (Olfson et al., 
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1999), which affects social security and welfare costs. These individuals are disproportionately 
associated with violence (Soyka, 2000) and incarceration (McNiel et al., 2005), which often lead 
to excessive legal costs in addition to exorbitant healthcare costs. Previous studies also note that 
this population is at an increased risk for HIV and hepatitis (Hoff & Rosenheck, 1999), both of 
which, again, increase healthcare costs. Of additional concern is the general safety of the rest of 
the population, as both HIV and hepatitis can be transmitted to those outside of the dual 
diagnosis population.  
All of these factors suggest PES facilities are a pragmatic and ideal place for training 
clinicians to properly triage this population to proper treatment, thus filling a hole in our 
healthcare system—establishing a place where those with dual diagnosis could receive 
appropriate and evidence-based care. For a first step, given the prevalence of this population 
found in methadone clinics, these clinics provide an ideal setting in which to implement 
immediate treatment improvement for this population. The implementation would be quite 
simple to adopt across these clinics, considering how close their current model is to the one this 
study found effective for treatment of the population in question.   
Methadone Clinics 
The adoption of this model by methadone clinics could be a great start in revolutionizing 
treatment for a population which, historically, has suffered remarkably and been exceptionally 
difficult to treat. Given the number of methadone clinic patients in the United States and the 
correlation with mental illness and substance abuse, these clinics may be the most common 
health care destination for individuals with dual diagnosis. We can begin making tremendous 
strides in effective treatment amongst this population in these locations. Methadone clinics 
already provide counseling services because substance abuse counseling is required for its 
patients. However, substance abuse counseling, in most cases, is the only mode of counseling 
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offered. In order to provide a significantly more effective model of care, methadone clinics 
simply need to implement a mental health component by adding mental health counselors to their 
staff, while leaving the existing model in place. The exact cost of adding mental health 
counseling to methadone clinics is unknown. However, because of the national opioid epidemic, 
government funding to treat this population and address the epidemic has grown exponentially. 
Clinics that employ a model that has been shown to improve treatment outcomes and save on 
healthcare costs by decreasing PES visits would be prime candidates for funding.  
Methadone clinics present an ideal place to implement this model, given the high number 
of dual diagnosis patients that they serve. Furthermore, these sites are an ideal location for future 
research on testing and modifying this model, providing empirical evidence that illustrates the 
effectiveness of this treatment modality. The practical application of this dual treatment model 
and the subsequent anticipated improved outcome rate suggests a revised, more comprehensive 
model for treating individuals with dual diagnosis. While methadone clinics serve a huge portion 
of patients with dual diagnosis, they only serve those with an opioid use disorder. This leaves a 
large portion of dual diagnosis patients without proper treatment. We have already identified that 
a large percentage of individuals using or abusing any type of substance are likely to be suffering 
from un underlying mental health condition. This model of care is easily replicated among those 
suffering from both mental illness and substance use disorder.  
Substance Abuse in General  
These findings suggest that integrative care (both MHC and SAC) is effective in treating 
dual diagnosis. Additionally, given the high percentage of people with co-occurring mental 
illness and substance abuse issues, these findings indicate that substance use may, in many cases, 
be a maladaptive, self-discovered treatment for mental illness and not necessarily a disorder in 
and of itself. The National Comorbidity Survey found that, of those with a lifetime SUD, 41.0%–
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65.5% have at least one mental disorder (Kessler et al., 1996).  There is no proof that an even 
higher percentage of those with a SUD do not have an underlying mental illness. Thus, given the 
high percentages of comorbidity, it raises the important clinical question of how often untreated 
mental illness underlies the substance abuse disorder. In most substance abuse recovery models, 
it is reported that abstinence alone is not effective. This implies that if a problem still exists once 
the individual is properly detoxed, no longer chemically dependent, and no longer using the 
substance, then there is a psychological element to their illness. Until that psychological element 
is addressed, the user will often need their substance, as it is their self-discovered treatment for 
their underlying psychological condition. This suggests that associated or underlying mental 
health issues should always be considered and/or addressed when treating substance abuse 
conditions. Provided that this is true, and a significant percentage of substance abuse cases 
involve a self-discovered treatment for an underlying untreated mental illness, the substance 
abuse becomes a new problem, and needs to be addressed—necessitating the need for integrative 
care. The findings of this study expose a hole in our healthcare system that warrants a new, more 
effective model of care.   
New Model for All Dual Diagnoses 
A new, more inclusive model is warranted for those suffering from dual diagnoses. The 
opportunity for methadone clinics to adopt this integrative model through simple modifications 
to their current model presents an exciting option—a model that provides both substance abuse 
and mental health treatment to patients regardless of whether the patient formally carries an 
additional psychiatric/mental health diagnosis. This model, if successful, could be applied to all 
substance abuse treatment programs, not exclusively to opioid use disorders. 
Currently, treatment in general for those with substance abuse issues often involves PES, 
intensive outpatient, or inpatient care. All of these options are costly, while intensive outpatient 
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and inpatient care both require a great deal of the patients’ time and, in some instances, their 
autonomy. Convincing individuals suffering from substance abuse to commit to an inpatient or 
an outpatient program can be daunting. Even when they do commit, retention is often a problem 
and there is no continuity of care. Therefore, a model similar to the methadone clinic model, with 
the addition of mental health treatment in an integrated care setting, and which assumes the 
prominence of dual diagnosis, appears to be a more clinically realistic, effective, and ultimately 
more cost-effective model. 
Based on what we have identified, including the high rates of comorbid mental illness 
with substance abuse, as well as costly collateral health conditions such as disease, namely HIV 
and hepatitis, and our current failure to effectively treat this population, this study strongly 
suggests a more holistically oriented integrated care model that involves medical doctors, 
psychopharmaceutical prescribers, substance abuse counselors, and mental health counselors. 
Patients would have their physical needs met by the medical doctor or nurse practitioner, their 
psychopharmaceutical needs met by either a psychiatrist or psychiatric nurse, their substance 
abuse needs met by their substance abuse counselor, and their mental health needs met by their 
mental health counselor. Considering the results of this study, which indicate that those who 
receive integrative care access PES less, we can assume that those who receive integrative care 
would not only prevent acceleration of the substance use, but also prevent or decrease associated 
consequences—such as violence, incarceration, and disease—as well as reduce costly PES visits. 
One also supposes that those costs associated with intensive outpatient and inpatient care would 
be reduced dramatically.  Ultimately, this model increases quality care for a suffering population 
while decreasing the overall healthcare and welfare costs for the rest of the country.  
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Training  
The intent of this study was to examine alternative ways of treating those with dual 
diagnosis, more specifically measuring the effectiveness of integrated care. In the literature 
review, we explored models that use variations of integrated treatment. Most of them did not 
provide conclusive results but did, however, imply valuable ideas to consider as we move 
forward in our quest to improve treatment for this suffering population. Given that the study 
identified that a high percentage of people with SAD have a co-occurring psychiatric disorder, 
we can argue that most or all with SAD have underlying mental health issues, whether there is a 
formal psychiatric diagnosis or not, and a significant percentage of this population may have 
initiated substance use as a self-discovered treatment for untreated mental health issues, leading 
eventually to a comorbid substance abuse disorder. Therefore, we conclude that maybe the root 
issue is often not being addressed by substance abuse counseling only, thereby leaving treatment 
incomplete. With confidence, we hypothesize that adding psychotherapy to SAC would 
significantly improve outcomes for treatment of this population.  
For training purposes, it is important to specifically recall the addition of supportive-
expressive psychotherapy to substance abuse counseling, given the long-term success and 
protective factors it conferred, which were revealed in the literature review. Therapy does not 
always generate immediate results and outcomes frequently are ever-evolving.  It is because of 
these very reasons that the supportive-expressive psychotherapy findings are so encouraging and 
should be considered when treating this population. If we are considering the long-term effects 
of treatment and desire to decrease recidivism, then it is imperative that we pay close attention to 
the limited but existing scientific literature. Although supportive-expressive psychotherapy did 
not show greater improvements during treatment, patients who received it showed gains beyond 
treatment, which indicates that the overall recovery trajectory points in the direction of outcome 
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improvement over the long term—a goal every health provider should value when treating a 
patient. Moreover, the significant improvement in family and social relationships, which 
supportive-expressive psychotherapy plus GDC positively affected above all other approaches, 
speaks volumes when considering long-term progress. Positive family and social relations serve 
as one of the greatest protective factors with both mental illness and substance abuse. This alone 
warrants great merit when aiming to improve treatment of both substance abuse and mental 
illness.  
There is an abundance of literature which indicates that, in most cases, psychotherapy 
prides itself on having a positive relationship with the patient, commonly referred to as the 
therapeutic alliance. Many scholars note that the therapeutic alliance is imperative for positive 
treatment outcomes. Mental illness and substance abuse, which the author would suggest are 
intimately interrelated, often evolve from a maladaptive relationship. Based on that theory, one 
might posit that a potential answer is to experience a relationship with a mental health 
professional that allows for emotional exploration, integration, and expression in a safe 
supportive context. In conclusion, as we continue our mission toward improving treatment for 
this suffering population and training clinicians to facilitate better long-term outcomes, the 
relational approach of supportive-expressive psychotherapy is a practical training option, and one 
that has already revealed great promise.  
Study Limitations 
Although the study produced encouraging results, there were several limitations. There 
were various diagnoses to contend with. Additionally, there was insufficient data, which 
prevented the researchers from controlling for the nature of the PES visits and the participants’ 
access to resources, as well as their previous treatment experience.  
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Diagnosis Variability 
To begin with, this study included a sample size with various diagnoses that complicated 
variable control and invited the potential for multiple extraneous variables. As we know, 
different diagnoses come with a diverse profile of symptoms. Some symptoms may be more 
severe, while some may induce or influence risky behavior. For instance, a sample size with a 
greater portion of psychosis might look significantly different than a sample size with little to no 
psychosis.  Individuals with Bipolar I or II not only present symptomatically different than 
someone with anxiety, but they also present symptomatically different from each other, given the 
varying degrees of a manic episode involved with Bipolar I versus the hypomanic episodes 
associated with Bipolar II. If one group contains 45% individuals with disorders involving mania 
or psychosis and the other group contains only 10%, it may not matter what kind of treatment 
each group is receiving, as the group with the more severe symptoms is likely to produce less 
favorable outcomes under the measurement being discussed.  
Data Limitations  
Because we used archival data, there was potentially significant information unavailable 
for collection. This unavailable data included: the nature of the PES visits, availability of 
resources amongst participants, and prior treatment experience. Additionally, because certain 
demographic data—such as ethnicity, SES, and marital status—were not consistently reported or 
collected, these items were not included. Therefore, only gender and age were collected, which 
compromises and limits the generalizability of this study.   
Nature of PES Visit. The nature of the participants’ PES visits could have provided this 
study with insight into the severity of the diagnosis and how closely related the nature of the visit 
was with the diagnosis. For instance, we could conclude that experiencing a distressing event 
that induces a trauma-infused response could be a collateral consequence of a person with dual 
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diagnosis, landing them in PES, but it does not inform us of how well that particular individual is 
dealing with their condition or how well therapy (or the lack thereof) is affecting their condition.  
An individual could end up in psychiatric services for numerous reasons. Knowing the precise 
reason would inform us whether or not it should be included in our outcome measurements. 
Moreover, while we know that stress plays a significant role in symptom expression and 
psychotherapy is designed to reduce stress, we do not entirely know the precise biological 
mechanisms that induce an experience such as a manic episode. A person with Bipolar I may be 
doing well in therapy and show no signs indicating concerns with their condition but still suffer a 
manic episode by an arbitrary stressor that requires PES, but ultimately, has nothing to do with 
current treatment or lack thereof. Again, this type of information would inform us as to whether 
it should be included in our outcome measures.  
Resources. An individual’s availability of resources (in both variety and in regard to 
socioeconomic status) significantly influences symptom expression and severity, and ultimately, 
the need for PES. An individual without social support versus someone with a cadre of social 
support will, most likely, fare differently regardless of their receipt of integrative care versus 
substance abuse care only. As social support is a protective factor against poor mental health 
outcomes, we know that someone who has healthy social support will likely have an advantage 
over someone who does not. Therefore, knowledge of an individual’s available resources would 
have enabled us to control for the variable in our measurements. As this sample was pulled from 
an impoverished region of San Francisco, there was a predictably high rate of homelessness. An 
individual who is homeless would likely present with different outcomes than an individual with 
safe, sustainable housing—regardless of the fact that they received the exact same course of 
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treatment. If housing data had been available, it would have enabled us to control for this 
variable as well, producing more reliable results.  
Previous treatment. Overall length of treatment is associated with better outcomes. An 
individual that received therapy for several years before their PES visit data were included, will 
likely have an advantage over someone who had never received therapy, regardless of which 
group they are in.  There is a trajectory of growth one might expect over the course of therapy. It 
would not be fair to measure the effectiveness of an intervention using a person that has 
experienced 10 years of psychotherapy compared to one that has only experienced 3 years. This 
is not to say that the individual who has received 10 years of therapy will automatically be more 
psychologically sound than the one who has only received 3 years, but it does invite an 
unfairness that needs to be factored into this discussion. If these data had been available, we 
would have controlled for it and produced more reliable and conclusive results.  
Direction for Future Research 
There are numerous directions for future research. As mentioned before, this study 
included a sample size with various diagnoses that complicated variable control and invited the 
potential for multiple extraneous variables. In future studies, ideally, researchers would use a 
sample with only one co-occurring mental illness to control for diverse symptom expression, 
such as depression, in order to reduce extraneous variables and produce more reliable results.  
Because the study used archival data, participant data were limited. Future studies would 
benefit from a self-designed study with a sample that could provide more information about the 
participants. This study could not identify why participants were accessing PES—there could 
have been a myriad of reasons. A study that could identify if the PES visit was directly related to 
the diagnosis could produce more reliable results and having the precise reason would inform the 
researcher whether or not it should be included in the outcome measurements. 
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In future research, having knowledge of participant resources would be beneficial, as 
well. This study was not able to identify social or socioeconomic resources per participant. 
Resources impact the overall welfare of individuals.  A participant who has significantly 
healthier social support or a higher socioeconomic status will likely have an advantage over 
someone with less. Knowledge of a participant’s available resources would enable future 
researchers to control for these variables in their measurements. Housing status data would also 
assist future  research. This sample was drawn from an area with a disproportionate amount of 
homelessness, but housing status was not indicated in the data set. A participant without a home 
would be at a disadvantage compared to one with a home. Regardless of the type of treatment 
received, a participant who is homeless would likely present with different outcomes than an 
individual with safe, sustainable housing. If future researchers have these data, they would be 
able to control for this variable as well, producing more reliable results.  
Further, this study did not contain data that accurately indicated whether or not 
participants had received treatment prior to this study or how much treatment they may or may 
not have received. As previously mentioned, overall length of treatment is associated with better 
outcomes. It would be unfair to measure the effectiveness of an intervention using a participant 
that has experienced 10 years of psychotherapy versus one that has only experienced 3 years. A 
participant with significantly less treatment experience than another participant would be at a 
distinct disadvantage. Having these data would help future researchers control for this variable 
and produce more reliable results.  
When conducting future research, we suggest a larger sample size that includes more 
demographic data. If future studies contain a larger sample that includes participant’s race, 
ethnicity, SES, employment, and education, in addition to age and gender, the study’s findings 
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would then be significantly more generalizable, and additionally, might potentially signal the 
need for more targeted interventions for subgroups within this generalized population.  
Lastly, because this study discovered positive outcomes when adding supportive-
expressive therapy to substance abuse counseling in follow-up measures, that were not yet found 
in the measurements taken during the course or treatment, future researchers interested in the 
long-term effects of treatment would want to routinely conduct follow-up measures to determine 
the true effectiveness of adding psychotherapy to substance abuse counseling when treating an 
individual with dual diagnosis.   
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